Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Ian M. Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C. Newton, Huiling Zhen, Luis Feliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn

Journal title: Cancer Discovery

Journal publisher: American Association for Cancer Research Inc.

Published year: 2020

Published pages: CD-20-0766

DOI identifier: 10.1158/2159-8290.cd-20-0766

ISSN: 2159-8274